You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Details for New Drug Application (NDA): 078660

✉ Email this page to a colleague

« Back to Dashboard

NDA 078660 describes ENOXAPARIN SODIUM, which is a drug marketed by Amphastar Pharms Inc, Nanjing King-friend, Sandoz Inc, Amphastar Pharm, Be Pharms, Gland, Sandoz, Shenzhen Techdow, and Zydus Pharms, and is included in ten NDAs. It is available from three suppliers. Additional details are available on the ENOXAPARIN SODIUM profile page.

The generic ingredient in ENOXAPARIN SODIUM is enoxaparin sodium. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.

Summary for 078660

Tradename:	ENOXAPARIN SODIUM
Applicant:	Sandoz Inc
Ingredient:	enoxaparin sodium
Patents:	0

Medical Subject Heading (MeSH) Categories for 078660

Anticoagulants
Fibrinolytic Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INTRAVENOUS, SUBCUTANEOUS			Strength	300MG/3ML (100MG/ML)
Approval Date:	Nov 28, 2011	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.